Vincent Capponi, Chief Operating Officer at Cytosorbents Corp (CTSO), sold 7,154 shares at $9.00 ($64K) on 2018-05-15, disclosed to the SEC on 2018-05-17.
Scheduled sale ($64k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 3,154 | $28K | 44.1% |
| 2 | $9.00 | 4,000 | $36K | 55.9% |
| Total | $9.00 avg | 7,154 | $64K | 100% |
| Filing → |
| CTSO | BUY | 2022-06-22 | $4K | — | Filing → |
| CTSO | BUY | 2022-06-21 | $6K | — | Filing → |
| CTSO | BUY | 2022-05-25 | $10K | — | Filing → |